Published February 17, 2022 | Version v1
Journal article Open

Long-term clinical outcomes of COVID-19 patients treated with imatinib

  • 1. Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, Amsterdam, The Netherlands
  • 2. Department of Epidemiology and Data Science, Amsterdam University Medical Centers, The Netherlands

Description

Long-term clinical outcomes of COVID-19 patients treated with imatinib

Files

PIIS2213260022000522.pdf

Files (460.6 kB)

Name Size Download all
md5:72ce50042687913845436f7840808567
460.6 kB Preview Download

Additional details

Related works

Is derived from
Journal article: 10.1016/S2213-2600(22)00052-2 (DOI)

Funding

Impentri – Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS). 101005142
European Commission